China: Partnering for innovations in commercial health insurance  

Published on October 16, 2023

China commercial health insurance (CHI) features vibrant growth on one hand, and complexities and variances on the other. A strategic approach is key for major pharma and medtech pharmaceutical firms to prioritize CHI opportunities, and to take part in the ongoing optimizations and innovations.  

Distinct CHI archetypes 

China CHI has seen strong growth over recent years, with vibrant development of different schemes ranging from premium insurances targeting the high-net-worth segment, to the more mainstream ones like Million-RMB CHI, which appeals to the middle-age and middle-income population. Disease-care insurances also offer comprehensive coverage mainly to those with certain preconditions like oncology and chronic disease…

Continue reading on website
Other news

Manage for Profit Seminar

October 11, 2023
After a period of rapid growth driven by high inflation levels and insatiable consumer spending, we are entering a new situation: demand is coming down. Consumers are experiencing the effects of decreased purchasing power, while companies cut investments as they are confronted with interest rates that have not been witnessed for a long time. As a result, companies can no longer rely on revenue gro

Retail investments study 2024: Business Models at a Tipping Point?

October 16, 2023
Simon-Kucher’s retail investments study 2024 is out! We have examined the shifts in retail investors' behavior, emerging trends, and the impact of regulatory changes on investment providers for the European market. We seamlessly merge insights from data, research, and industry best practices in the study. Ready to dive into a selection of our most remarkable findings?The retail investor market, me